Wan Gao Pharmaceutical

Wangao Pharmaceutical is a Chinese pharmaceutical company specializing in the research, development, production, and sale of chemical drugs. The company focuses on high-growth therapeutic areas including cardiovascular diseases, diabetes, digestive system disorders, and oncology. Wangao operates integrated facilities for both Active Pharmaceutical Ingredients (APIs) and finished dosage forms, maintaining a strong presence in the domestic Chinese market with a portfolio of generic and innovative medications. Headquartered in Jiangsu, the company leverages its R&D centers in Beijing and Shanghai to advance its pipeline of complex generics and improved new drugs. Wangao is recognized for its technical expertise in drug delivery systems and its commitment to high-quality manufacturing standards. The company follows an integrated business model that ensures supply chain stability and cost-efficiency across its diverse product lines.